Stanford University
Showing 521-540 of 1,809 Results
-
Denise Geraci
Administrative Director, Science, Technology and Society
BioAs the administrative director for the Program in Science, Technology, and Society, I am responsible for managing and overseeing the program’s operational, financial, and human resources. I hold a PhD in anthropology and have long been interested in applied social science and public anthropology. I am happy to support a program that trains students to think critically about how social contexts and processes relate to practices of science and technology. My professional interests also include community-university partnerships and international education. Before joining STS, I worked for Stanford Global Studies, managing professional development programs for community college faculty interested in internationalizing college curriculum. I also worked for Stanford's Center for Latin American Studies, and have more than ten years’ experience conducting research, working, and studying in Latin America, primarily Mexico, Bolivia, and Guatemala.
-
Vera Geranpayeh
Ph.D. Student in German Studies, admitted Autumn 2024
Ph.D. Minor, Feminist, Gender, and Sexuality StudiesCurrent Research and Scholarly InterestsVera Geranpayeh is a PhD candidate in German Studies. Her dissertation investigates how Vera Geranpayeh is a PhD Student in German Studies and PhD Minor in Feminist, Gender, and Sexuality Studies at Stanford University. Her dissertation investigates how gender structures narrative movement in medieval German romance, focusing on minor female figures who remain structurally marginal yet narratively indispensable. She develops a framework for understanding how these figures catalyze plot progression through epistemic authority, mediation, and mobility, while remaining excluded from patriarchal mechanisms of narrative closure, such as minne and marriage.
In addition to her dissertation, she is developing a critical edition and English translation of a vernacular 1593 Franconian aristocratic household cookbook Ein koch büchlein vonn allerley speiß wie man sie kochen soll (1593). This project examines domestic authorship, women’s custodianship of culinary and medical knowledge, and the transmission of embodied expertise across generations.
Her research is further informed by training in Yiddish and a focused interest in early modern Yiddish texts, particularly domestic and practical writing, charms and magical materials, and the Yiddish Epic tradition.
She is also the student initiator of SCRIPTA, an interdisciplinary research group on gender, knowledge, and agency in premodern manuscript cultures, which combines theoretical discussion with hands-on archival work in Stanford’s Special Collections and hosts workshops with invited scholars.
She is the recipient of the Clayman Institute’s 2025 Marilyn Yalom Research Prize.
Her broader research spans queer survival, female bonds, and desire in nineteenth-century and fin-de-siècle German literature. She is the recipient of the Clayman Institute’s 2025 Marilyn Yalom Research Prize. -
Daniel Aaron Gerber, MD
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. Gerber is a critical care cardiologist and medical director of Stanford's cardiac ICU. He has dual subspecialty training in cardiovascular and critical care medicine and additional board certification in echocardiography. He completed his residency in internal medicine, fellowship in cardiovascular medicine, and an additional fellowship in critical care medicine at Stanford University and joined as faculty in 2021 as a Clinical Assistant Professor in the Department of Medicine’s Division of Cardiovascular Medicine.
Dr. Gerber manages the full spectrum of heart and vascular conditions with a focus on critically ill patients with life-threatening cardiovascular disease. He is active in medical education, teaching introductory echocardiography to Stanford medical students and residents, co-directing the Stanford Critical Care Medicine Critical Care Ultrasound Program, and lecturing nationally on critical care echocardiography and point-of-care ultrasonography at the Society of Critical Care Medicine’s annual congress. Finally, Dr. Gerber’s research interests focus on optimizing cardiac intensive care, including working with the Critical Care Cardiology Trials Network (CCCTN) - a national network of tertiary cardiac ICUs coordinated by the TIMI Study Group - and studying acute mechanical circulatory support techniques to improve patient outcomes and care processes. -
J. Christian Gerdes
Professor of Mechanical Engineering, Emeritus
BioChris Gerdes is a Professor Emeritus of Mechanical Engineering at Stanford University. His laboratory studies how cars move, how humans drive cars and how to design future cars that work cooperatively with the driver or drive themselves. Vehicles in the lab include X1, a student-built electric, steer-by-wire test vehicle; Takumi, a modified Toyota Supra capable of autonomous drifting in tandem with another car; and Marty, the electrified, automated, drifting DeLorean. Chris' interests in vehicle safety extend to ethics and government policy, having helped to develop the US Federal Automated Vehicle Policy while serving as the first Chief Innovation Officer of the US Department of Transportation.
-
Yael Gernez
Clinical Associate Professor, Pediatrics - Immunology
BioMy clinic focuses on solving the molecular puzzles that underlie rare allergic and immunologic diseases to shed light on fundamental principles governing allergy, inflammation and immune system defects. My goal is to find better and safer therapies for my patients with rare diseases that include autoinflammation, autoimmunity and primary immune deficiency. It is important to highlight that every patient requires individualized therapeutic approaches based on their underlying genetic problem and the types and severity of their clinical manifestations. For some patients, a hematopoietic stem cell transplant (HSCT) is curative while for others, a targeted drug therapy, such as a biologic or small molecule agent, is most suitable. In some cases, a truly novel therapy may be required, .e.g., anti-sense oligonucleotide therapy to suppress aberrant gene splicing or adoptive cellular therapy. My passion is to provide the best personalized therapy for our patients with allergy and immunology diseases. This often requires performing very specialized functional assays and in some cases in enlisting laboratories with specific expertise or interest in particular genetic disorders.
